Cargando…

Overcoming challenges due to enhanced biomedical waste generation during COVID-19 pandemic

Biomedical wastes (BMWs) are potentially infectious to the environment and health. They are co-dependent and accumulative during the ongoing coronavirus disease-2019(COVID-19) pandemic. In India the standard treatment processes of BMWs are incineration, autoclaving, shredding, and deep burial; howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Ojha, Priti Chhanda, Satpathy, Swati Sucharita, Ojha, Akash Kumar, Sukla, Lala Behari, Pradhan, Debabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988481/
https://www.ncbi.nlm.nih.gov/pubmed/35398414
http://dx.doi.org/10.1016/j.scitotenv.2022.155072
_version_ 1784682970185990144
author Ojha, Priti Chhanda
Satpathy, Swati Sucharita
Ojha, Akash Kumar
Sukla, Lala Behari
Pradhan, Debabrata
author_facet Ojha, Priti Chhanda
Satpathy, Swati Sucharita
Ojha, Akash Kumar
Sukla, Lala Behari
Pradhan, Debabrata
author_sort Ojha, Priti Chhanda
collection PubMed
description Biomedical wastes (BMWs) are potentially infectious to the environment and health. They are co-dependent and accumulative during the ongoing coronavirus disease-2019(COVID-19) pandemic. In India the standard treatment processes of BMWs are incineration, autoclaving, shredding, and deep burial; however, incineration and autoclaving are the leading techniques applied by many treatment providers. These conventional treatment methods have several drawbacks in terms of energy, cost, and emission. But the actual problem for the treatment providers is the huge and non-uniform flow of the BMWs during the pandemic. The existing treatment methods are lacking flexibility for the non-uniform flow. The Government of India has provisionally approved some new techniques like plasma pyrolysis, sharp/needle blaster, and PIWS-3000 technologies on a trial basis. But they are all found to be inadequate in the pandemic. Therefore, there is an absolute requirement to micromanage the BMWs based on certain parameters for the possible COVID-19 like pandemic in the future. Segregation is a major step of the BMW management. Its guideline may be shuffled as segregation at the entry points followed by collection instead of the existing system of the collection followed by segregation. Other steps like transportation, location of treatment facilities, upgradation of the existing treatment facilities, and new technologies can solve the challenges up to a certain extent. Technologies like microwave treatment, alkaline hydrolysis, steam sterilization, biological treatment, catalytic solar disinfection, and nanotechnology have a lot of scopes for the treatment of BMWs. Hi-tech approaches in handling and transportation are found to be fruitful in the initial steps of BMW management. End products of the treated BMWs can be potentially fabricated for the application in the built environment. Some policies need to be re-evaluated by the health care facilities or government administrations for efficient BMW management.
format Online
Article
Text
id pubmed-8988481
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-89884812022-04-07 Overcoming challenges due to enhanced biomedical waste generation during COVID-19 pandemic Ojha, Priti Chhanda Satpathy, Swati Sucharita Ojha, Akash Kumar Sukla, Lala Behari Pradhan, Debabrata Sci Total Environ Review Biomedical wastes (BMWs) are potentially infectious to the environment and health. They are co-dependent and accumulative during the ongoing coronavirus disease-2019(COVID-19) pandemic. In India the standard treatment processes of BMWs are incineration, autoclaving, shredding, and deep burial; however, incineration and autoclaving are the leading techniques applied by many treatment providers. These conventional treatment methods have several drawbacks in terms of energy, cost, and emission. But the actual problem for the treatment providers is the huge and non-uniform flow of the BMWs during the pandemic. The existing treatment methods are lacking flexibility for the non-uniform flow. The Government of India has provisionally approved some new techniques like plasma pyrolysis, sharp/needle blaster, and PIWS-3000 technologies on a trial basis. But they are all found to be inadequate in the pandemic. Therefore, there is an absolute requirement to micromanage the BMWs based on certain parameters for the possible COVID-19 like pandemic in the future. Segregation is a major step of the BMW management. Its guideline may be shuffled as segregation at the entry points followed by collection instead of the existing system of the collection followed by segregation. Other steps like transportation, location of treatment facilities, upgradation of the existing treatment facilities, and new technologies can solve the challenges up to a certain extent. Technologies like microwave treatment, alkaline hydrolysis, steam sterilization, biological treatment, catalytic solar disinfection, and nanotechnology have a lot of scopes for the treatment of BMWs. Hi-tech approaches in handling and transportation are found to be fruitful in the initial steps of BMW management. End products of the treated BMWs can be potentially fabricated for the application in the built environment. Some policies need to be re-evaluated by the health care facilities or government administrations for efficient BMW management. Elsevier B.V. 2022-08-01 2022-04-07 /pmc/articles/PMC8988481/ /pubmed/35398414 http://dx.doi.org/10.1016/j.scitotenv.2022.155072 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review
Ojha, Priti Chhanda
Satpathy, Swati Sucharita
Ojha, Akash Kumar
Sukla, Lala Behari
Pradhan, Debabrata
Overcoming challenges due to enhanced biomedical waste generation during COVID-19 pandemic
title Overcoming challenges due to enhanced biomedical waste generation during COVID-19 pandemic
title_full Overcoming challenges due to enhanced biomedical waste generation during COVID-19 pandemic
title_fullStr Overcoming challenges due to enhanced biomedical waste generation during COVID-19 pandemic
title_full_unstemmed Overcoming challenges due to enhanced biomedical waste generation during COVID-19 pandemic
title_short Overcoming challenges due to enhanced biomedical waste generation during COVID-19 pandemic
title_sort overcoming challenges due to enhanced biomedical waste generation during covid-19 pandemic
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988481/
https://www.ncbi.nlm.nih.gov/pubmed/35398414
http://dx.doi.org/10.1016/j.scitotenv.2022.155072
work_keys_str_mv AT ojhapritichhanda overcomingchallengesduetoenhancedbiomedicalwastegenerationduringcovid19pandemic
AT satpathyswatisucharita overcomingchallengesduetoenhancedbiomedicalwastegenerationduringcovid19pandemic
AT ojhaakashkumar overcomingchallengesduetoenhancedbiomedicalwastegenerationduringcovid19pandemic
AT suklalalabehari overcomingchallengesduetoenhancedbiomedicalwastegenerationduringcovid19pandemic
AT pradhandebabrata overcomingchallengesduetoenhancedbiomedicalwastegenerationduringcovid19pandemic